|
|
|
| Effectiveness evaluation of pharmaceutical care network Europe classification system for solving drug-related problems in intensive care unit |
| FAN Fangfang1,2 ZHAO Shengjun1,2 YAO Li1,2 HU Lan1,2 ZHENG Lili1,2 JIANG Qian1,2 |
1 Department of Pharmacy, Xinjiang Uygur Autonomous Regional Academy of Traditional Chinese Medicine, Xinjiang Uygur Autonomous Region, Urumqi 830000, China;
2.Department of Pharmacy, the Affiliated Traditional Medical Hospital, Xiniang Medical University, Xinjiang Uygur Autonomous Region, Urumqi 830000, China |
|
|
|
Abstract Objective To evaluate the effectiveness of pharmaceutical care network Europe （PCNE） classification system for solving drug-related problems (DRPs) in intensive care unit (ICU). Methods Clinical pharmacists interfered with DRPs in 283 ICU patients admitted to the Affiliated Traditional Medical Hospital, Xiniang Medical University from January 2018 to December 2019. PCNE-DRPs classification system V9.0 was used to classify the “problem” “cause” “intervention plan” “acceptance of intervention plan” “DRPs status” of patients with DRPs, and JMP software was used for statistical analysis. Results DRPs occurred in 90 patients. The DRPs question categories focused on “safety of treatment” and “efficacy of treatment”. The reason categories mainly focus on“drug selection” “dose selection” “treatment course” “drug use process”. All interventions were at the “doctor level”. Among the acceptance category of intervention programs, “intervention acceptance” accounted for 97.8%; in the status category of intervention programs,“problem solving” accounted for 87.8%. Conclusion The introduction of PCNE classification system can improve the ability of clinical pharmacists to discove and solve DRPs, improve the ability and efficiency of clinical pharmacists in pharmaceutical care, promote clinical rational drug use, inhance the quality of pharmaceutical service, and ensure the safe drug use of patients.
|
|
|
|
|
|
[1] 曹伟，方洁.临床药师参与重症医学科药物治疗实践的体会[J].药学实践杂志，2017，35（4）：371-374.
[2] 兰博，林春燕，许晓刚，等.本院重症医学科超说明书用药合理性分析[J].药学与临床研究，2021，29（1）：57.
[3] 廖敏辉，任野萍，廖曙桃，等.基于MTM和PCNE分类系统对高尿酸血症患者开展药学监护实践[J].中国药师，2020，23（9）：1776-1780.
[4] van Mil JW，Westerlund LO，Hersberger KE，et al. Drug-related problem classification systems [J]. Ann Pharmacother，2004，38（5）：859-867.
[5] Allemann SS，van Mil JW，Botermann L，et al. Pharmaceutical care：the PCNE definition 2013 [J]. Int J Clin Pharm，2014，36（3）：544-555.
[6] Griese-Mammen N, Hersberger KE, Messerli M，et al. PCNE definition of medication review：reaching agreement [J]. Int J Clin Pharm，2018，40（5）：1188-1208.
[7] Su YJ，Yan YD，Wang WJ，et al. Drug-related problems among hospitalized cancer pain patients：an investigative single-arm intervention trial [J]. Ann Palliat Med，2020， 10（2）：2008-2017.
[8] 张莎，王婧，祝德秋.引入PCNE分类系统对社区慢病患者进行药学监护的实践探索[J].中南药学，2020，18（6）：1051-1056.
[9] 张萍，廖赟，吕丹，等.运用PCNE分类体系对癌痛患者麻醉镇痛药物的处方分析[J].中国药师，2018，21（6）：1051-1054.
[10] 王樱华，陈跃宇，孟拥军，等.欧洲医药保健网分类系统在普外科围术期基础疾病药物相关问题中的应用[J].中国药师，2019，22（8）：1454-1457.
[11] 瞿慧君，廖赟，张萍，等.运用PCNE分类系统对COPD和脑卒中患者进行药学监护的前瞻性队列研究[J].中国医院药学杂志，2018，38（21）：2276-2280.
[12] 刘丽亚，温小明，杨西晓，等.引入PCNE分类系统对2型糖尿病患者开展MTM的实践探索[J].中国药房，2019， 30（19）：2685-2690.
[13] 梁佳，谢珊珊，张卫芳，等.PCNE分类系统在抗凝门诊药物相关问题中的应用[J].中国药师，2019，22（7）：1291-1294.
[14] 刘霞，余自成，胡亮，等.临床药师对癫痫患者开展综合用药管理的实践[J].中南药学，2021，19（2）：360-364.
[15] 陈清清，廖赟，金昭，等.PCNE分类系统在心内科相关药物问题中的应用[J].解放军药学学报，2018，34（2）：188-190.
[16] 宗宇桐，闫素英，沈江华，等.基于欧洲药学监护联盟协会分类系统的骨科用药相关问题分析[J].临床药物治疗杂志，2020，18（10）：44-48.
[17] 王聪，胡建莉，陈旭，等.癌症疼痛患者病历中阿片类药物相关问题分析[J].医药导报，2021，40（1）：71-74.
[18] 苏昊凡，李晓玲，张青霞.PCNE分类系统在心脏内科医药联合门诊中的应用研究[J].中国药物应用与监测，2021，18（1）：56-60.
[19] 吕丹，李玲，胡学谦，等.欧洲医药保健网分类系统在肿瘤科药物相关问题中的应用[J].中国药师，2017，20（12）：2198-2200.
[20] Krzy■aniak N，Paw?覥owska I，Bajorek B. Pharmaceutical Care in NICUs in Australia and Poland：Attitudes and Perspectives of Doctors and Nurses [J]. J Perinat Neonatal Nurs，2019，33（4）：E27-E37.
[21] Leopoldino RD，Santos MT，Costa TX，et al. Drug related problems in the neonatal intensive care unit：incidence，characterization and clinical relevance [J]. BMC Pediatr，2019，19（1）：134.
[22] Zhu Y，Liu C，Zhang Y，et al. Identification and resolution of drug-related problems in a tertiary hospital respiratory unit in China [J]. Int J Clin Pharm，2019，41（6）：1570-1577.
[23] Nascimento ARFD，Leopoldino RWD，Santos METD，et al. DRUG-RELATED PROBLEMS IN CARDIAC NEONATES UNDER INTENSIVE CARE [J]. Rev Paul Pediatr，2020， 38：e2018134.
[24] Martins RR，Silva LT，Lopes FM. Impact of medication therapy management on pharmacotherapy safety in an intensive care unit [J]. Int J Clin Pharm，2019，41（1）：179-188.
[25] Li Q，Qu HJ，Lv D，et al. Drug-related problems among hospitalized patients with COPD in mainland China [J]. Int J Clin Pharm，2019，41（6）：1507-1515. |
|
|
|
